Denca is under control at SAFC plant in Scotland

Published: 6-Jun-2011
Manufacturing Pharmaceutical

Will supply full control system for IPB2 facility at Irvine

Automation control systems specialist Denca Controls has been awarded the E&I controls contract for the new IPB2 facility being designed by laboratory and cleanroom specialist T Squared for SAFC, a leader in biochemical and organic chemical products, based in Irvine, Scotland.

The project involves building and automating a cell culture media, reagents and buffer solutions manufacturing system, CIP system, WFI/SIP system and filling system at the SAFC facility.

Denca, based in Widnes, Cheshire, will supply a full control system consisting of E&I design, manufacture of system control panels, including motor control panel, PLC/instrument control panel and multiple remote I/O, solenoid, HMI panels, system software and associated validation documentation to GAMP (Good Automated Manufacturing Practices), installation and testing/commissioning through to client handover.

See more

You may also like

Manufacturing

Denca designs control system for pharma facility

Read more
Project in Liverpool worth £500,000

Trending Articles

  1. Manufacturing Chemist Stand Side with Piramal Pharma Solutions We discover what exhibitors at CPHI 2025 are showcasing LIVE!
  2. Thermo Fisher launches general purpose centrifuges with natural refrigerant cooling New X and S Series models offer high performance with reduced environmental impact
  3. Rentschler Biopharma and Coriolis Pharma partner to deliver integrated biopharma development and manufacturing solutions The German-based CDMO and CRDO will offer unified formulation-to-manufacturing services to accelerate biologics development. The collaboration aims to cut complexity, timelines and risk for global biopharma clients
  4. Thermo Fisher Scientific doubles down on investment in Asia New and expanded Bioprocess Design Centres will provide local expertise, advanced technologies and tailored support for biopharma innovators throughout the region
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Revolutionising temperature control: the benefits of thermal insulated coatings in the pharmaceutical industry Insulation is safety critical in pharmaceutical factories, where hot pipes and equipment pose a significant burn risk to workers. Yet traditional approaches often fall short in terms of durability and longevity … and can be expensive to install and maintain

Upcoming event

From powder to granules: a deep dive into wet granulation methods

14 January 2026 | Virtual See all

You may also like

Manufacturing

Denca designs control system for pharma facility

Project in Liverpool worth £500,000
Pharmaceutical

Cytiva and Fida Biosystems unite to improve molecular insight for faster drug discovery

The collaboration will combine complementary and orthogonal approaches to simplify workflows and improve confidence in experimental results
Manufacturing

Irish CDMOs Gaelic Labs and Athlone merge to expand penicillin manufacturing capacity

Gaelics acquisition of the leading developer and manufacturer of oral dose Beta-Lactams will strengthen its market position and enhance the company's manufacturing capabilities
Manufacturing

BIA report highlights UK innovation and efficiency in global cell and gene therapy sector

The report provides a comprehensive analysis of the UK's cell and gene therapy sector, focusing on the innovative technologies and strategic investments that are driving scale
Manufacturing

Vacuubrand at a glance - New brochure available to download

In the UK, Labtex supplies a comprehensive range of high-quality laboratory and instrumentation vacuum pumps, gauges and controllers for both coarse and fine vacuums, from trusted partners at Vacuubrand
Manufacturing

SeaBeLife partners with Unither Pharmaceuticals for ophthalmic drug production

The new partnership aims to produce clinical and commercial batches of ophthalmic formulation of SeaBeLife’s drug candidate SBL03 to treat degenerative disorders of the retina, such as dry age-related macular degeneration
Pharmaceutical

SGS achieves breakthrough in infectious disease research with launch of novel RSV A-strain

Derived from a 2015 circulating strain, SGS's novel RSV-A challenge agent offers a closer match to circulating RSV viruses than strains currently used in clinical research
Subscribe now